Progyny(PGNY),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

PGNY Progyny

Market Closed 11-06 16:00:00 EST

34.84

+0.47

+1.37%

盘后34.70

-0.14-0.40%

19:54 EST

High34.90	Low33.34	Vol1.55M
Open33.67	D1 Closing34.37	Amplitude4.54%
Mkt Cap2.57B	Tradable Cap2.31B	Total Shares73.65M
T/O53.58M	T/O Rate2.34%	Tradable Shares66.27M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"PGNY","market":"US","secType":"STK","nameCN":"Progyny","latestPrice":34.84,"timestamp":1793998800000,"preClose":34.37,"halted":0,"volume":1550907,"hourTrading":{"tag":"盘后","latestPrice":34.7,"preClose":34.84,"latestTime":"19:54 EST","volume":208941,"amount":7278499.31,"timestamp":1794012895310,"change":-0.14,"changeRate":-0.004018,"amplitude":0.014925},"delay":0,"changeRate":0.013674716322374339,"floatShares":66269166,"shares":73647300,"eps":1.078892,"marketStatus":"Market Closed","change":0.47,"latestTime":"11-06 16:00:00 EST","open":33.67,"high":34.9,"low":33.34,"amount":53582875.287659995,"amplitude":0.045388,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":1.078892,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1794214800000},"marketStatusCode":7,"adr":0,"listingDate":1571976000000,"exchange":"NASDAQ","adjPreClose":34.37,"preHourTrading":{"tag":"盘前","latestPrice":33.64,"preClose":34.37,"latestTime":"09:29 EST","volume":11178,"amount":383645.033964,"timestamp":1793975399999,"change":-0.73,"changeRate":-0.021239,"amplitude":0.094559},"postHourTrading":{"tag":"盘后","latestPrice":34.7,"preClose":34.84,"latestTime":"19:54 EST","volume":208941,"amount":7278499.31,"timestamp":1794012895310,"change":-0.14,"changeRate":-0.004018,"amplitude":0.014925},"volumeRatio":1.073669,"impliedVol":0.4831,"impliedVolPercentile":0.2908},"requestUrl":"/m/hq/s/PGNY","defaultTab":"news","newsList":[{"id":"2681894969","title":"Progyny CFO Mark S. Livingston Reports Sale of $64,170 in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2681894969","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":1,"itemType":null,"share":"https://ttm.financial/m/news/2681894969?lang=en_us&edition=fundamental","pubTime":"2026-11-07 05:08","pubTimestamp":1793999333,"startTime":"0","endTime":"0","summary":"Progyny CFO Mark S. Livingston Reports Sale of $64,170 in Common SharesProgyny Chief Financial Officer Mark S. Livingston sold 2,139 shares of Common Stock on November 4, 2026.The sale price was $30 p","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261106:nNDL4M7R2m:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Progyny CFO Mark S. Livingston Reports Sale of $64,170 in Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PGNY","LU1878469433.USD","BK4154"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681006837","title":"Progyny (PGNY) Stock Looks Fairly Valued Despite Raised Earnings Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2681006837","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681006837?lang=en_us&edition=fundamental","pubTime":"2026-11-06 02:21","pubTimestamp":1793902900,"startTime":"0","endTime":"0","summary":"BBailey PembertonNovember 5, 2026","market":"hk","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=240/https://images.simplywall.st/asset/industry/6034000-choice2-card/1789111483077","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=240/https://images.simplywall.st/asset/industry/6034000-choice2-card/1789111483077"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-pgny/progyny/news/progyny-pgny-stock-looks-fairly-valued-despite-raised-earnin","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-pgny/progyny/news/progyny-pgny-stock-looks-fairly-valued-despite-raised-earnin","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["PGNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681300824","title":"Progyny up over 13%, on Track for Highest Close Since April 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2681300824","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681300824?lang=en_us&edition=fundamental","pubTime":"2026-11-06 01:05","pubTimestamp":1793898300,"startTime":"0","endTime":"0","summary":"Progyny, Inc.  is currently at $34.06, up $3.96 or 13.16%--Would be highest close since April 12, 2024, when it closed at $34.20--On pace for largest percent increase since May 8, 2026, when it rose 23.8%--Currently up six of the past seven days--Currently up two consecutive days; up 17.21% over this period--Best two day stretch since the two days ending May 11, 2026, when it rose 17.69%--Up 32.63% year-to-date--Down 48.9% from its all-time closing high of $66.66 on Nov. 8, 2021--Up 89.12% from 52 weeks ago , when it closed at $18.01--Would be a new 52-week closing high--Up 108.96% from its 52-week closing low of $16.30 on April 10, 2026--Traded as high as $35.50; highest intraday level since April 9, 2024, when it hit $36.36--Up 17.94% at today's intraday high; largest intraday percent increase since May 8, 2026, when it rose as much as 24.01%All data as of 12:03:10 PM ETSource: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PGNY","LU1878469433.USD","BK4154"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681071553","title":"Progyny price target raised to $36 from $31 at BofA","url":"https://stock-news.laohu8.com/highlight/detail?id=2681071553","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681071553?lang=en_us&edition=fundamental","pubTime":"2026-11-05 22:21","pubTimestamp":1793888518,"startTime":"0","endTime":"0","summary":"BofA analyst Allen Lutz raised the firm’s price target on Progyny (PGNY) to $36 from $31 and keeps a Buy rating on the shares after what the firm c...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/progyny-price-target-raised-to-36-from-31-at-bofa-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/progyny-price-target-raised-to-36-from-31-at-bofa-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PGNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681020500","title":"Progyny Price Target Raised to $35.00/Share from $31.00 by Cantor Fitzgerald","url":"https://stock-news.laohu8.com/highlight/detail?id=2681020500","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681020500?lang=en_us&edition=fundamental","pubTime":"2026-11-05 20:33","pubTimestamp":1793881980,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/PGNY/analyst-ratings","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PGNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681025285","title":"Progyny price target raised to $38 from $33 at Citizens","url":"https://stock-news.laohu8.com/highlight/detail?id=2681025285","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681025285?lang=en_us&edition=fundamental","pubTime":"2026-11-05 19:00","pubTimestamp":1793876452,"startTime":"0","endTime":"0","summary":"Citizens analyst Constantine Davides raised the firm’s price target on Progyny (PGNY) to $38 from $33 and keeps an Outperform rating on the shares....","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/progyny-price-target-raised-to-38-from-33-at-citizens-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/progyny-price-target-raised-to-38-from-33-at-citizens-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CFG","PGNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681410840","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Envista Holdings (NVST), Progyny (PGNY) and PROCEPT BioRobotics (PRCT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2681410840","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681410840?lang=en_us&edition=fundamental","pubTime":"2026-11-05 16:41","pubTimestamp":1793868090,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Envista Holdings (NVST), Progyny (PGNY) and PROCEPT BioRobotics (...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-envista-holdings-nvst-progyny-pgny-and-procept-biorobotics-prct-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-envista-holdings-nvst-progyny-pgny-and-procept-biorobotics-prct-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","LU2324357040.USD","LU1201861165.SGD","IE00B19Z6F94.USD","LU0130103400.USD","BK4588","LU0130518102.USD","PGNY","BK4585","XLV","HCSG","XBI","BK4137","LU0477156797.USD","LU1878469433.USD","LU0029874061.USD","LU0128526141.USD","NVST","BK4154","LABU","LU0648000940.SGD","BK4082","IE0034390439.USD","PRCT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681764041","title":"Progyny (PGNY) Receives a Hold from Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2681764041","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681764041?lang=en_us&edition=fundamental","pubTime":"2026-11-05 16:41","pubTimestamp":1793868065,"startTime":"0","endTime":"0","summary":"Barclays analyst Peter Warendorf maintained a Hold rating on Progyny today and set a price target of $30.00. Warendorf covers the Healthcare sector...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/progyny-pgny-receives-a-hold-from-barclays-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/progyny-pgny-receives-a-hold-from-barclays-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1878469433.USD","LABU","BK4585","PGNY","BK4154","BK4588","BK4581","XLV","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681096816","title":"Progyny, Inc. Reports Results for the Quarter Ended September 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2681096816","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681096816?lang=en_us&edition=fundamental","pubTime":"2026-11-05 06:01","pubTimestamp":1793829687,"startTime":"0","endTime":"0","summary":"Progyny, Inc. reports results for the quarter ended September 30 - Earnings SummaryProgyny, Inc.PGNY.OQreported quarterly adjusted earnings of 32 cents per share for the quarter ended September 30, hi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261104:nL5N46L3FX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4154","LU1878469433.USD","PGNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681060072","title":"Progyny Grants Allison Swartz 8,160 Restricted Stock Units","url":"https://stock-news.laohu8.com/highlight/detail?id=2681060072","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681060072?lang=en_us&edition=fundamental","pubTime":"2026-11-05 05:20","pubTimestamp":1793827215,"startTime":"0","endTime":"0","summary":"Progyny grants Allison Swartz 8,160 restricted stock unitsProgyny granted EVP, GC Allison Swartz 8,160 shares of common stock on Nov. 2, 2026.Swartz also received 11,370 stock options with a $29.41 ex","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261104:nNDLbdV0Jr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4154","LU1878469433.USD","PGNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681060232","title":"Progyny Q3 Revenue Rises Driven by New Clients","url":"https://stock-news.laohu8.com/highlight/detail?id=2681060232","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681060232?lang=en_us&edition=fundamental","pubTime":"2026-11-05 05:12","pubTimestamp":1793826739,"startTime":"0","endTime":"0","summary":"Progyny Q3 revenue rises driven by new clientsOverviewU.S. women's health benefits provider's Q3 revenue rose 8.9%, slightly beating analyst expectationsAdjusted EBITDA for Q3 slightly exceeded analys","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261104:nL2N46L1CO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","BK4154","ADUS","HNGE","IE00BN0W2T93.GBP","LU2065171311.SGD","LU2065170008.USD","INNV","LU1878469433.USD","LU2065169927.USD","IE00BN0W2W23.USD","PGNY","LU2065171402.SGD","IE00BN0W2V16.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681620340","title":"Progyny Q3 Adj. EPS $0.52 Beats $0.31 Estimate, Sales $341.254M Beat $340.924M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2681620340","media":"Benzinga Earnings","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681620340?lang=en_us&edition=fundamental","pubTime":"2026-11-05 05:02","pubTimestamp":1793826153,"startTime":"0","endTime":"0","summary":"Progyny Q3 Adj. EPS $0.52 Beats $0.31 Estimate, Sales $341.254M Beat $340.924M Estimate","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/quote/PGNY","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PGNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681106274","title":"Progyny Q3 EPS USD 0.32","url":"https://stock-news.laohu8.com/highlight/detail?id=2681106274","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681106274?lang=en_us&edition=fundamental","pubTime":"2026-11-05 05:02","pubTimestamp":1793826122,"startTime":"0","endTime":"0","summary":"BRIEF-Progyny Q3 EPS USD 0.32Nov 04 (Reuters) - Progyny Q3 gross profit USD 83.74 million.Q3 revenue USD 341.254 million vs. IBES estimate USD 340.9 millionQ3 net income USD 26.252 millionQ3 adjusted EBITDA USD 58.439 million vs. IBES estimate USD 57.9 millionQ3 pretax profit USD 36.416 million","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261104:nPLXFDZ79K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1878469433.USD","BK4154","PGNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2681060896","title":"Progyny Outlook Q4 Revenue Growth 8.3-14.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2681060896","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2681060896?lang=en_us&edition=fundamental","pubTime":"2026-11-05 05:01","pubTimestamp":1793826062,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261104:nPLXFDZ79K:10","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PGNY","BK4154","LU1878469433.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679280152","title":"Is Progyny (PGNY) Priced At A Premium For Its Earnings?","url":"https://stock-news.laohu8.com/highlight/detail?id=2679280152","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679280152?lang=en_us&edition=fundamental","pubTime":"2026-10-30 00:37","pubTimestamp":1793291863,"startTime":"0","endTime":"0","summary":"Progyny has delivered a mixed experience for shareholders over the past few years, and the recent share price level puts a sharper spotlight on what investors are really paying for its earnings. With the stock closing at US$27.87, the key issue is how that price lines up with the fertility benefits specialist's ability to generate profit today.\n\nProgyny's share price has fallen 53.8% over the past 5 years, which puts long term holders squarely focused on whether current earnings now justify...","market":"us","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6034000-choice2-card/1789111483077","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6034000-choice2-card/1789111483077"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-pgny/progyny/news/is-progyny-pgny-priced-at-a-premium-for-its-earnings","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-pgny/progyny/news/is-progyny-pgny-priced-at-a-premium-for-its-earnings","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["PGNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111821121","title":"Earning Preview: Progyny this quarter’s revenue is expected to increase by 13.92%, and institutional views are bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=1111821121","media":"Earnings Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111821121?lang=en_us&edition=fundamental","pubTime":"2026-10-29 00:50","pubTimestamp":1793206228,"startTime":"0","endTime":"0","summary":"Abstract Progyny will report its quarterly results on November 4, 2026 Post-Mkt; this preview summarizes consensus revenue, profitability and EPS expectations, reviews last quarter’s operating...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Earning Preview: Progyny this quarter’s revenue is expected to increase by 13.92%, and institutional views are bullish","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PGNY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678496456","title":"Progyny Study Finds Racial Disparities in Fertility Treatment Initiation Despite Benefits Access","url":"https://stock-news.laohu8.com/highlight/detail?id=2678496456","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678496456?lang=en_us&edition=fundamental","pubTime":"2026-10-28 21:52","pubTimestamp":1793195533,"startTime":"0","endTime":"0","summary":"Progyny Study Finds Racial Disparities in Fertility Treatment Initiation Despite Benefits AccessProgyny announced research showing racial and ethnic disparities in fertility treatment initiation persi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261028:nNDL6rxgr6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","IE00BGHQF748.EUR","NDAQ","SG9999014005.SGD","IE00BN0W2T93.GBP","LU2095319765.USD","SG9999014013.SGD","BK4112","IE00BQXX3C00.GBP","PGNY","BK4585","IE00B64PRP62.GBP","IE00BN0W2V16.EUR","LU2210150020.SGD","LU0314104364.USD","IE00BKPKM429.USD","SG9999014021.USD","IE00BQXX3F31.USD","LU1878469433.USD","BK4588","BK4154","BCDF","IE00BQXX3D17.EUR","LU2210149790.SGD","IE00BN0W2W23.USD","SG9999014039.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678017103","title":"Progyny (PGNY) Could Be 18% Undervalued On New Menopause Outcomes Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2678017103","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678017103?lang=en_us&edition=fundamental","pubTime":"2026-10-27 21:24","pubTimestamp":1793107463,"startTime":"0","endTime":"0","summary":"Progyny (PGNY) is back in focus after publishing new clinical outcomes data on its Menopause and Midlife program, with the study reporting symptom improvements for more than 70% of participating members.\nProgyny shares closed at US$28.13, with the 1 month share price return up 10.57% even as the 3 month share price return declined 8.55%. That mix of near term momentum against a weaker recent patch sits beside a 1 year total shareholder return of 44.03%, but a 5 year total shareholder return...","market":"nz","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6034000-choice2-card/1789111483077","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6034000-choice2-card/1789111483077"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-pgny/progyny/news/progyny-pgny-could-be-18-undervalued-on-new-menopause-outcom","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-pgny/progyny/news/progyny-pgny-could-be-18-undervalued-on-new-menopause-outcom","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["PGNY","LU1878469433.USD","BK4154"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678192166","title":"Progyny Study Finds Menopause Symptoms Improve in 70.8% of Members","url":"https://stock-news.laohu8.com/highlight/detail?id=2678192166","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678192166?lang=en_us&edition=fundamental","pubTime":"2026-10-26 23:25","pubTimestamp":1793028349,"startTime":"0","endTime":"0","summary":"Progyny Study Finds Menopause Symptoms Improve in 70.8% of MembersProgyny today announced clinical study results showing improved menopause symptoms among members receiving care through its Menopause ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261026:nNDL7SS4Qy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0314104364.USD","LU1878469433.USD","NDAQ","IE00BGHQF748.EUR","SG9999014013.SGD","BK4154","BK4585","LU2095319765.USD","SG9999014005.SGD","PGNY","BK4588","BK4112","IE00BN0W2W23.USD","SG9999014039.USD","IE00BN0W2V16.EUR","IE00BN0W2T93.GBP","IE00BQXX3C00.GBP","BCDF","SG9999014021.USD","LU2210149790.SGD","IE00BKPKM429.USD","IE00BQXX3D17.EUR","IE00B64PRP62.GBP","IE00BQXX3F31.USD","LU2210150020.SGD","IE00B3QW5Z07.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678197830","title":"New Progyny Study Finds Significant Improvement in Menopause Symptoms Through Connected Care Model","url":"https://stock-news.laohu8.com/highlight/detail?id=2678197830","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678197830?lang=en_us&edition=fundamental","pubTime":"2026-10-26 23:25","pubTimestamp":1793028300,"startTime":"0","endTime":"0","summary":"More than 70% of members in the study reported symptom improvement, with the greatest gains among those receiving both personalized coaching and menopause-trained provider careNEW YORK, Oct.  26, 2026","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/26/3388341/0/en/new-progyny-study-finds-significant-improvement-in-menopause-symptoms-through-connected-care-model.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PGNY","BK4154","LU1878469433.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.progyny.com;investors.progyny.com","stockEarnings":[{"period":"1week","weight":0.1936},{"period":"1month","weight":0.2646},{"period":"3month","weight":0.2399},{"period":"6month","weight":0.4688},{"period":"1year","weight":0.9345},{"period":"ytd","weight":0.3567}],"compareEarnings":[{"period":"1week","weight":-0.027},{"period":"1month","weight":-0.0539},{"period":"3month","weight":-0.0491},{"period":"6month","weight":-0.0032},{"period":"1year","weight":0.0969},{"period":"ytd","weight":0.0783}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides surrogacy and adoption reimbursement programs for employers. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.","yearOnYearQuotes":[{"month":1,"riseRate":0.714286,"avgChangeRate":0.045948},{"month":2,"riseRate":0.142857,"avgChangeRate":-0.053355},{"month":3,"riseRate":0.428571,"avgChangeRate":-0.002239},{"month":4,"riseRate":0.714286,"avgChangeRate":0.017743},{"month":5,"riseRate":0.571429,"avgChangeRate":0.041564},{"month":6,"riseRate":0.714286,"avgChangeRate":0.020466},{"month":7,"riseRate":0.714286,"avgChangeRate":0.031717},{"month":8,"riseRate":0.571429,"avgChangeRate":-0.007346},{"month":9,"riseRate":0.285714,"avgChangeRate":-0.075296},{"month":10,"riseRate":0.428571,"avgChangeRate":-0.00596},{"month":11,"riseRate":0.75,"avgChangeRate":0.184853},{"month":12,"riseRate":0.571429,"avgChangeRate":0.032965}],"exchange":"NASDAQ","name":"Progyny","nameEN":"Progyny"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Progyny(PGNY),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Progyny(PGNY) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Progyny,PGNY,Progyny股票,Progyny股票老虎,Progyny股票老虎国际,Progyny行情,Progyny股票行情,Progyny股价,Progyny股市,Progyny股票价格,Progyny股票交易,Progyny股票购买,Progyny股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Progyny(PGNY),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Progyny(PGNY) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}